EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma

Xiaofei Wang iD, Penghua Zhang iD, Ke Deng iD

Analytical Cellular Pathology · 18.08.2022 · 2022 · 1-17

DOI: 10.1155/2022/1435173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, erschienen am 18.08.2022. Verfasst von Xiaofei Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of ICU, Qilu Hospital of Shandong University (Qingdao), Qingdao, 266035 Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, L-Lactate Dehydrogenase, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MYC is a notorious oncogene in a vast network of malignancies, whereas liver-specific microRNA- (miR-) 122-5p is downregulated in hepatocellular cancer (HCC). Here, we studied the possible correlation between these two and their involvement in glycolysis in HCC. MYC was overexpressed in HCC tissues and cells compared to normal liver tissues and normal hepatocytes NHC, which predicted a poor survival of HCC sufferers. Functional assays demonstrated that silencing of MYC inhibited the glycolysis in HCC cells, as evidenced by significantly weaker glucose consumption, lactate production, adenosine triphosphate (ATP) levels, and downregulated HK1 and HK2 protein expression. Moreover, MYC bound to the miR-122-5p promoter and repressed the miR-122-5p expression. Rescue experiments showed that miR-122-5p inhibitor rescued the diminished glycolysis after MYC silencing. In addition, lactate dehydrogenase (LDHA) was identified as a downstream target of miR-122-5p. The overexpression of LDHA mitigated the effects of si-MYC and miR-122-5p mimic on glycolysis of HCC cells, respectively. In conclusion, the MYC/miR-122-5p/LDHA axis modulates glycolysis in HCC cells and possibly affects HCC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularL-Lactate DehydrogenaseLiver NeoplasmsMicroRNAsProto-Oncogene Proteins c-mycCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGlycolysisHumans

Substanzen

MIRN122 microRNA, humanMicroRNAsProto-Oncogene Proteins c-mycL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of ICU, Qilu Hospital of Shandong University (Qingdao), Qingdao, 266035 Shandong, China.
  • Department of Healthy Management Center, Qilu Hospital of Shandong University (Qingdao), Qingdao, 266035 Shandong, China.
  • Department of General Surgery, Qilu Hospital of Shandong University (Qingdao), Qingdao, 266035 Shandong, China.

ORCID-Profile: Xiaofei Wang, Penghua Zhang, Ke Deng

Zitieren

APA

Wang, X., Zhang, P., & Deng, K. (2022). MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma. Analytical Cellular Pathology, 2022, 1-17. https://doi.org/10.1155/2022/1435173

Vancouver

Wang X, Zhang P, Deng K. MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma. Analytical Cellular Pathology. 2022;2022:1-17. doi:10.1155/2022/1435173

BibTeX
@article{Wang2022,
  author = {Wang, Xiaofei and Zhang, Penghua and Deng, Ke},
  title = {MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma},
  journal = {Analytical Cellular Pathology},
  year = {2022},
  volume = {2022},
  pages = {1--17},
  doi = {10.1155/2022/1435173}
}
Kostenlos starten →